Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Interviews as Topic × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 17 Prostatic Neoplasms 15 Neoplasms 14 Colorectal Neoplasms 13 Hematopoietic and Lymphatic System Neoplasm 9 Hematologic Neoplasms 8 Lung Neoplasms 7 Ovarian Neoplasms 4 Multiple Myeloma 4 Malignant Solid Neoplasm 4 Lymphoma 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Endometrial Neoplasms 3 Advanced Malignant Solid Neoplasm 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity-Related Malignant Neoplasm 2 Mouth Neoplasms 2 Motor Activity 2 Leukemia 2 Head and Neck Carcinoma 2 Genital Neoplasms, Female 2 Genetic Predisposition to Disease 2 Depression 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Behavior 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡